These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1811918)

  • 21. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
    Gardiner SJ; Gearry RB; Begg EJ; Zhang M; Barclay ML
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human kidney thiopurine methyltransferase. Purification and biochemical properties.
    Woodson LC; Weinshilboum RM
    Biochem Pharmacol; 1983 Mar; 32(5):819-26. PubMed ID: 6838629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: a factor for differing results of TPMT measurements.
    Kröplin T; Fischer C; Iven H
    Eur J Clin Pharmacol; 1999 Jun; 55(4):285-91. PubMed ID: 10424321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylation of 6-mercaptopurine and 6-thioguanine by thiopurine S-methyltransferase. A comparison of activity in red blood cell samples of 199 blood donors.
    Kröplin T; Iven H
    Eur J Clin Pharmacol; 2000 Jul; 56(4):343-5. PubMed ID: 10954350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of three methods for measuring thiopurine methyltransferase activity in red blood cells and human leukemia cells.
    Karim H; Appell ML; Fotoohi A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():80-5. PubMed ID: 24113235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse thiopurine methyltransferase pharmacogenetics: monogenic inheritance.
    Otterness DM; Weinshilboum RM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):817-24. PubMed ID: 3559976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
    Snow JL; Gibson LE
    Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
    Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
    J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
    Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity.
    Liu C; Janke LJ; Yang JJ; Evans WE; Schuetz JD; Relling MV
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):287-293. PubMed ID: 28623449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation pharmacogenetics: thiopurine methyltransferase as a model system.
    Weinshilboum RM
    Xenobiotica; 1992; 22(9-10):1055-71. PubMed ID: 1441597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of thiopurine drugs on DNA methylation in relation to TPMT expression.
    Hogarth LA; Redfern CP; Teodoridis JM; Hall AG; Anderson H; Case MC; Coulthard SA
    Biochem Pharmacol; 2008 Oct; 76(8):1024-35. PubMed ID: 18708030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients].
    Gisbert JP; Gomollón F; Cara C; Luna M; González-Lama Y; Pajares JM; Maté J; Guijarro LG
    Med Clin (Barc); 2005 Sep; 125(8):281-5. PubMed ID: 16159550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiopurine methyltransferase activity in a Korean population sample of children.
    Park-Hah JO; Klemetsdal B; Lysaa R; Choi KH; Aarbakke J
    Clin Pharmacol Ther; 1996 Jul; 60(1):68-74. PubMed ID: 8689814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
    Lennard L; Welch JC; Lilleyman JS
    Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.
    Lennard L; Van Loon JA; Lilleyman JS; Weinshilboum RM
    Clin Pharmacol Ther; 1987 Jan; 41(1):18-25. PubMed ID: 3467886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
    Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
    Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
    Brouwer C; De Abreu RA; Keizer-Garritsen JJ; Lambooy LH; Ament K; ter Riet PG; van Wering ER; Trijbels FJ; Veerman AJ; Hoogerbrugge PM; Bökkerink JP
    Eur J Cancer; 2005 Mar; 41(4):613-23. PubMed ID: 15737567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender difference in red blood cell thiopurine methyltransferase activity.
    Klemetsdal B; Wist E; Aarbakke J
    Scand J Clin Lab Invest; 1993 Nov; 53(7):747-9. PubMed ID: 8272762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TPMT Polymorphism: When Shield Becomes Weakness.
    Katara P; Kuntal H
    Interdiscip Sci; 2016 Jun; 8(2):150-155. PubMed ID: 26297310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.